Dutch guideline for the management of hypertensive crisis - 2010 revision

Netherlands Journal of Medicine

Volumn 69, Issue 5, 2011, Pages 248-255

  van den Born, B J H ^a   Beutler, J J ^b   Gaillard, C A J M ^c   de Gooijer, A ^d   van den Meiracker, A H ^e   Kroon, A A ^f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Guideline; Hypertensive crisis; Hypertensive emergencies; Hypertensive urgencies; Management; Renal sufficiency

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CREATININE; ESMOLOL; GLYCERYL TRINITRATE; KETANSERIN; LABETALOL; LOOP DIURETIC AGENT; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE; URAPIDIL;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADRENAL CORTEX INSUFFICIENCY; ANGINA PECTORIS; AORTA DISSECTION; ARTICLE; AWARENESS; BLOOD PRESSURE; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLETE HEART BLOCK; CONTINUOUS INFUSION; CORONARY CARE UNIT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EMERGENCY CARE; EVIDENCE BASED PRACTICE; FIBRINOLYTIC THERAPY; HEADACHE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; HYPERTENSION RETINOPATHY; HYPERTENSIVE CRISIS; HYPERTENSIVE EMERGENCY; HYPERTENSIVE URGENCY; HYPOKALEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER FAILURE; LUNG EDEMA; MALIGNANT HYPERTENSION; MEAN ARTERIAL PRESSURE; MICROANGIOPATHY; NAUSEA; PATIENT CARE; PERIOPERATIVE HYPERTENSION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREECLAMPSIA; QT PROLONGATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SYSTOLIC HEART FAILURE; TACHYCARDIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VISUAL DISORDER; VOMITING; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CAPTOPRIL; EMERGENCY TREATMENT; HUMANS; HYPERTENSION; HYPERTENSIVE RETINOPATHY; INTERNAL MEDICINE; LABETALOL; NETHERLANDS; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE; PRACTICE GUIDELINES AS TOPIC;

EID: 80051479216     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006 Nov;24 (11):2299-304.
2. Stichting Registratie Nierfunctievervanging Nederland (RENINE). 2010.
3. Beutler JJ, Gaillard CA, de Gooijer A, van den Meiracker AH, Jorna ATM, Potter van Loon BJ. Richtlijn Hypertensieve Crisis. Van Zuiden Communications B.V. 2003.
4. Evidence-based Richtlijnontwikkeling. CBO; 2007.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.
6. van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005 Feb;45(2):246-51.
7. Immink RV, van den Born BJ, van Montfrans GA, Kim Y-S, Hollmann MW, van Lieshout JJ. Cerebral and systemic hemodynamics during treatment with sodium nitroprusside and labetalol in malignant hypertension. Hypertension. 2008;52:236-40.
8. Amraoui F, van Montfrans GA, van den Born BJ. Value of retinal examination in hypertensive encephalopathy. J Hum Hypertens. 2009 Oct 29.
9. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992 Aug;159(2):379-83.
10. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22;334(8):494-500.
11. Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet. 1998 Aug 1;352(9125):383-90.
12. Scheler S, Motz W, Strauer BE. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol. 1994 Mar 1;73(7):478-82.
13. Frishman WH, Strom JA, Kirschner M, Poland M, Klein N, Halprin S, et al. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade. Am J Cardiol. 1981 Nov;48(5):917-28.
14. Mann T, Cohn PF, Holman LB, Green LH, Markis JE, Phillips DA. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation. 1978 Apr;57(4):732-8.
15. Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation. 1976 Nov;54(5):766-73.
16. Durrer JD, Lie KI, van Capelle FJ, Durrer D. Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med. 1982 May 13;306(19):1121-8.
17. Gregorini L, Marco J, Palombo C, Kozakova M, Anguissola GB, Cassagneau B, et al. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. J Am Coll Cardiol. 1998 Apr;31(5):992-1001.
18. Gregorini L, Marco J, Kozakova M, Palombo C, Anguissola GB, Marco I, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation. 1999 Feb 2;99(4):482-90.
19. Schreiber W, Woisetschlager C, Binder M, Kaff A, Raab H, Hirschl MM. The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. Intensive Care Med. 1998 Jun;24(6):557-63.
20. Adams HP, Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May;38(5):1655-711.
21. Nederlandse Vereniging voor Neurologie. Richtlijn Diagnostiek, behandeling en zorg voor patiënten met een beroerte. Kwaliteitsinstituut voor de Gezondheidszorg CBO 2008.
22. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007 Oct 16;116(16):e391-e413.
23. O'Connor B, Luntley JB. Acute dissection of the thoracic aorta. Esmolol is safer than and as effective as labetalol. BMJ. 1995 Apr 1;310(6983):875.
24. Hoshino T, Ohmae M, Sakai A. Spontaneous resolution of a dissection of the descending aorta after medical treatment with a beta blocker and a calcium antagonist. Br Heart J. 1987 Jul;58(1):82-4.
25. Verner IR. Sodium nitroprusside: theory and practice. Postgrad Med J. 1974 Sep;50(587):576-81.
26. Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004 Apr;92(4):512-7.
27. Briggs RS, Birtwell AJ, Pohl JE. Hypertensive response to labetalol in phaeochromocytoma. Lancet. 1978 May 13;1(8072):1045-6.
28. Sheaves R, Chew SL, Grossman AB. The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma. Postgrad Med J. 1995 Jan;71(831):58-9.
29. Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med. 1992 Jul 30;327(5):361.
30. Brogan WC, III, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991 Aug;18(2):581-6.
31. Negus BH, Willard JE, Hillis LD, Glamann DB, Landau C, Snyder RW, et al. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am J Cardiol. 1994 Mar 1;73(7):510-3.
32. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006;(3):CD001449.
33. Hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence (NICE); 2010.
34. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996 Oct 23;276(16):1328-31.
35. Ledingham JG, Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Q J Med. 1979 Jan;48(189):25-41.
36. Haas DC, Streeten DH, Kim RC, Naalbandian AN, Obeid AI. Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. Am J Med. 1983 Dec;75(6):1071-6.
37. Mak W, Chan KH, Cheung RT, Ho SL. Hypertensive encephalopathy: BP lowering complicated by posterior circulation ischemic stroke. Neurology. 2004 Sep 28;63(6):1131-2.
38. Immink RV, van den Born BJ, van Montfrans GA, Koopmans RP, Karemaker JM, van Lieshout JJ. Impaired cerebral autoregulation in patients with malignant hypertension. Circulation. 2004 Oct 12;110(15):2241-5.
39. van den Born BJ, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007 Aug;20(8):900-6.
40. Hirschl MM, Binder M, Bur A, Herkner H, Woisetschlager C, Bieglmayer C, et al. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises. J Hum Hypertens. 1997 Mar;11(3):177-83.
41. David D, Dubois C, Loria Y. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. J Cardiothorac Vasc Anesth. 1991 Aug;5(4):357-61.
42. Bertolissi M, De Monte A, Giordano F. Comparison of intravenous nifedipine and sodium nitroprusside for treatment of acute hypertension after cardiac surgery. Minerva Anestesiol. 1998 Jul;64(7-8):321-8.
43. De Hert SG, Van der Linden PJ, Ten Broecke PW, Sermeus LA, Gillebert TC. Effects of nicardipine and urapidil on length-dependent regulation of myocardial function in coronary artery surgery patients. J Cardiothorac Vasc Anesth. 1999 Dec;13(6):677-83.
44. Kross RA, Ferri E, Leung D, Pratila M, Broad C, Veronesi M, et al. A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol. for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000 Oct;91(4):904-9.
45. Cottrell JE, Patel K, Turndorf H, Ransohoff J. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg. 1978 Mar;48(3):329-31.
46. Singbartl G, Metzger G. Urapidil-induced increase of the intracranial pressure in head-trauma patients. Intensive Care Med. 1990;16(4):272-4.
47. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003 Oct 25;327(7421):955-60.
48. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006;3:CD001449.
49. Morgan T, Anderson A. Interaction of slow-channel calcium blocking drugs with sodium restriction, diuretics and angiotensin converting enzyme inhibitors. J Hypertens Suppl. 1988 Dec;6(4):S652-S654.
50. Anderson GH, Jr., Howland T, Domescek R, Streeten DH. Effect of sodium balance and calcium channel blocking drugs on blood pressure responses. Hypertension. 1987 Sep;10(3):239-48.